| Title |
Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial
|
|---|---|
| Published in |
Osteoporosis International, November 2009
|
| DOI | 10.1007/s00198-009-1126-4 |
| Pubmed ID | |
| Authors |
N. Emaus, C. G. Gjesdal, B. Almås, M. Christensen, A. S. Grimsgaard, G. K. R. Berntsen, L. Salomonsen, V. Fønnebø |
| Abstract |
Vitamin K2 may preserve bone strength and reduce fracture risk. In this randomised double-blind placebo-controlled trial among healthy postmenopausal Norwegian women, 1 year supplementation of vitamin K2 in the form of Natto capsules had no effect on bone loss rates. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 1 | <1% |
| Unknown | 127 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 15% |
| Other | 15 | 12% |
| Student > Master | 15 | 12% |
| Student > Bachelor | 15 | 12% |
| Student > Ph. D. Student | 11 | 9% |
| Other | 25 | 20% |
| Unknown | 28 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 34% |
| Agricultural and Biological Sciences | 13 | 10% |
| Biochemistry, Genetics and Molecular Biology | 9 | 7% |
| Nursing and Health Professions | 8 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
| Other | 12 | 9% |
| Unknown | 37 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2023.
All research outputs
#1,306,253
of 26,017,215 outputs
Outputs from Osteoporosis International
#173
of 3,933 outputs
Outputs of similar age
#5,077
of 181,942 outputs
Outputs of similar age from Osteoporosis International
#1
of 11 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,933 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,942 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.